skip to content »


Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Joseph Jankovic, M.D.

Professor of Neurology

Distinguished Chair in Movement Disorders

Director, Parkinson's Disease Center and Movement Disorders Clinic

Clinical Service Area



Movement Disorders
Parkinson's Disease

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments




Medical School

M.D., University of Arizona College of Medicine, Tucson, Ariz.


Internal Medicine, Baylor College of Medicine, Houston, Texas


Neurology, The Neurological Institute, Columbia University, New York, N.Y.

Clinic Location

Baylor Neurology
Smith Tower
6550 Fannin, Suite 1801
Houston, Texas 77030

Clinical Interests

Movement disorders including Parkinson's disease and related neurodegenerative disorders, tremors, dystonia, Tourette's syndrome, Huntington's disease, and tardive dyskinesias

Research Interests

Epidemiology, pathophysiology, genetics and experimental therapeutics of movement disorders

Contact Information

Joseph Jankovic, M.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-7438
Fax: 713-798-6808

BCM Honors

  • 2010 Baylor College of Medicine Alumni Association Distinguished Faculty Award.
  • 2010 Fulbright & Jaworski LLP Faculty Excellence Award for Teaching and Evaluation and has become a member of the Academy of Distinguished Educators, which recognizes the educational scholarship of faculty members involved in all of the educational missions of Baylor College of Medicine.
  • Baylor College of Medicine Recognition Award for 30 years of service, 2008.
  • Distinguished Chair in Movement Disorders, presented by the Baylor College of Medicine Board of Trustees, 2008.

Awards (Selected out of 56)

  • Listed annually in "Houston's Top Docs", HTexas Magazine, 2004-present.
  • Listed annually in Who's Who in American Education, 2003-present.
  • Listed annually in the "Super Doctors", Texas Monthly, 2002-present.
  • Listed among the top 20 most cited PD researchers since 1985 (Sorensen AAn Weedon D, Journal of Parkinson's Disease, Volume1/Issue 1, 3-13, 2011).
  • 2011 Dystonia Medical Research Foundation Distinguished Service Award.
  • Selected as NIH Clinical Center "Great Teacher", 2009.
  • Featured in Lancet Neurology series called "in Context", in which "noteworthy physicians and other people who have made significant contributions to medicine over the years" are profiled. MacReady N. Joseph Jankovic: Mozart and Movement Disorders, Lancet Neurol 2009;8:786.
  • Lifetime Achievement Award, presented by the national Tourette Syndrome Association (TSA) recognizing "a lifetime of outstanding achievements in advancing research, education and clinical care for all people touched by Tourette syndrome", during the 5th Tourette Syndrome International Symposium, New York City, June 2009.
  • The First National Parkinson Foundation (NPF) Distinguished Service Award, 2007.
  • The American Academy of Neurology (AAN) Movement Disorders Research Award, sponsored by the Parkinson's Disease Foundation and given in recognition of "outstanding achievements in Movement Disorders research", presented at the 59th Annual Meeting of the AAN, Boston, May 2007 (Title of the award lecture: "Essential Tremor is a Risk Factor for Parkinson's Disease").

Grants (Funding) (Selected out of 15)

  • National Parkinson Foundation (NPF) Center of Excellence
  • Huntington's Disease Society of America (HDSA) Center of Excellence
  • Parkinson Research Endowment Fund (PREF)
  • Dystonia Medical Research Foundation
  • Cullen Foundation
  • Diana and Conrad Weil, Jr. Endowment for Neurological Research
  • William Stamps Farish Fund
  • Gordon and Mary Cain Foundation
  • Joe & Dora Levit Endowment
  • Ted & Irma Kaplen Endowment

Current Committee Memberships

  • ABC News and ABC 20/20
    Consultant, 2005 - present
  • American Academy of Neurology (AAN)
    Founding member, Movement disorder section, 1994 - present
    Member, Task force on the development of practice guidelines for the treatment of Tourette's syndrome (representing Movement Disorders Society), 2003 - present
    Member, Search committee for the editor of the AAN journal Neurology, 2005 - present
    Chair, Movement disorders research award subcommittee, 2011 - present
  • American Neurological Association (ANA)
    Member, Membership committee, 2006 - present
  • Baylor College of Medicine (BCM)
    Director, National Parkinson Foundation (NPF) Center of Excellence, 1992 - present
    Director, Parkinson's Disease Center and Movement Disorders Clinic, 1997 - present
    Director, Huntington's Disease Society of America (HDSA) Center of Excellence, 2002 - present
    Member, Executive council, Department of Neurology, 2004 - present
    Chair, Faculty appointments and promotions committee, Department of Neurology, 2004 - present
    Director, Tourette Syndrome Center and Childhood Movement Disorders Clinic, 2005 - present
  • Benign Essential Blepharospasm Research Foundation (BEBRF)
    Founding member, 1981 - present
    Member, Advisory board, 1992 - present
  • Duke University
    Consultant, Morris K. Udall Parkinson's Disease Research Center of Excellence, 2000 - present
  • Dystonia Study Group (DSG)
    Founding member, 1995 - present
    Member, Steering committee for botulinum toxin AB-CD study, 2000 - present
  • Editorial Boards
    Associate editor, Neurobase, 1992 - present
    Member, Česká and Slovenská Neurologie and Neurochirurgie, 1995 - present
    Member, Journal of Neurology, Neurosurgery and Psychiatry, 1995 - present
    Senior editor, Medlink Neurology, 1995 - present
    Member, Annals of Medical Sciences, 1996 - present
    Member, Neurology Network Commentary, 1996 - present
    Member, Acta Neurologica Scandinavica, 1997 - present
    Member, Journal of Neurological Sciences, official journal of the WFN, 2001 - present
    Member, Current Trends in Neurology, 2003 - present
    Member, Expert Review of Neurotherapeutics, 2003 - present
    Associate editor, International Journal of Clinical Medicine and Surgery, 2004 - present
    Co-editor, Therapy, 2004 - present
    Associate editor, The Botulinum Journal, 2007 - present
    Member, American Journal of Clinical Neurology, 2009 - present
    Member, Neurotherapeutics, official journal of the American Society for Experimental NeuroTherapeutics, 2010 - present
    Member, Tremor and Other Hyperkinetic Movements, 2010 - present
    Member, Journal of Parkinson's Disease, 2011 - present
  • Genzyme
    Member, Data monitoring committee for "A phase 1 open-label safety study of intrastriatal infusion of adeno-associated virus encoding human aromatic L-amino acid decarboxylase (AAV-hAADC-2) in subjects with mid- to late- stage Parkinson's disease", 2005 - present
  • Harvard University
    Member, Website advisory board for Parkinson's disease, Massachusetts General Hospital, 1995 - present
  • Huntington Disease Study Group (HDSG)
    Founding member, 1994 - present
  • International Neurotoxin Association (INA)
    Vice president, 2010 - present
  • Johns Hopkins University
    Member, Advisory board, Dystonia and spasticity practicum, 2009 - present
  • Michael E. DeBakey Veterans Affairs Medical Center
    Consultant, Advisory committee, Parkinson's Disease Research, Education, and Clinical Center (PADRECC), 2001 - present
  • Michael J. Fox Parkinson's Research Foundation
    Member, Executive scientific advisory board, 2010 - present
    Member, Biologics committee, Parkinson's Progression Markers Initiative (PPMI), 2011 - present
  • Movement Disorder Society (MDS)
    Founding member, 1985 - present
    Member, UPDRS task force subcommittee, 2003 - present
    Member, Website committee, 2005 - present
    Member, Nominating committee, 2007 - present
  • National Institute of Neurological Disorders and Stroke (NINDS)
    Member, Working group to develop Huntington's disease Common Data Elements (CDEs), 2010 - present
  • National Parkinson Foundation (NPF)
    Member, Clinical and scientific advisory board, 2009 - present
    Member, Peer-review committee, 2009 - present
  • Neurotoxin Institute (NTI)
    Founding member, 2002 - present
  • Parkinson Study Group (PSG)
    Founding member, 1985 - present
    Chair, Standards committee, 2008 - present
  • PSP Clinical Study Group
    Founding member, 1994 - present
  • Scientific Advisory Boards
    Member, Dystonia Medical Research Foundation (DMRF), Houston Chapter, 1986 - present
    Member, International Essential Tremor Foundation (IETF), 1988 - present
    Member, Tardive Dyskinesia-Tardive Dystonia Association, 1988 - present
    Member, National Spasmodic Dysphonia Association, 1990 - present
    Member, Associazione Italiana per la Ricarca sulla Distonia (ARD), Italy, 1992 - present
    Member, Worldwide Education and Awareness for Movement Disorders (WEMOVE), 1992 - present
    Member, Essential Tremor Genetics Consortium, 1996 - present
    Member, Myoclonus Research Foundation, 1998 - present
    Member, Tourette Syndrome Association (TSA), 2001 - present
    Member, Blue Bird Rett Center, BCM, 2004 - present
    Member, ALTROPANE-SPECT: Boston Life Sciences, 2005 - present
    Member, Eisai E2007 advisory board and steering committee, 2005 - present
    Member, Teva Pharmaceutical Industries Ltd., 2005 - present
    Member, Houston Area Parkinsonism Society (HAPS), 2006 - present
    Member, Merz Pharmaceuticals GmbH, 2006 - present
    Member, CD-PROBE charter and steering committee, 2008 - present
    Member, Safinamide (SETTLE, MOTION), Merck Serono/EMD Serono, 2009 - present
  • Tourette Syndrome Association (TSA) of Texas
    Chair, Medical advisory board, 2003 - present
  • Tourette Syndrome Study Group (TSSG)
    Founding member, 1991 - present
  • Tremor Research and Investigation Group (TRIG)
    Founding member, 1990 - present
  • World Federation of Neurology (WFN)
    Member, Research committee on Parkinson's disease and related disorders, 2001 - present

Journal Publications (Selected out of 823)

  • Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Reply: Dystonia after severe head injuries. Mov Disord. 2014;29(4):578-9. [View journal article]
  • Baizabal-Carvallo JF, Jankovic J. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014;17(1):104-6. [View journal article]
  • Baizabal-Carvallo JF, Jankovic J. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry. 2014;85(5):573-5. [View journal article]
  • Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry. 2014;85(5):567-72. [View journal article]
  • Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, et al. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014;261(7):1309-19. [View journal article]
  • Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014;10(6):337-48. [View journal article]
  • Deng H, Xiu X, Jankovic J. Genetic Convergence of Parkinson's Disease and Lysosomal Storage Disorders. Mol Neurobiol. 2014;:. [View journal article]
  • DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety. Neuromodulation. 2014;17(5):405-18. [View journal article]
  • Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A. IncobotulinumtoxinA (Xeomin(R)) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014;:. [View journal article]
  • Factor SA, Jankovic J, Friedman BW, Garber L, Gallagher EJ. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014;83(15):1388-9. [View journal article]

Books and Volumes (Selected out of 56)

  • Albanese A, Jankovic J, editors. Hyperkinetic movement disorders. Oxford, UK: Wiley-Blackwell; 2012. p. 1-390. (includes 75 videos accessible via QR app).
  • Daroff RB, Fenichel GM, Jankovic J, Maziotta J. Bradley's neurology in clinical practice. 6th ed. Philadelphia: Saunders Elsevier; 2012.
  • Jankovic J, editor. Current opinion in neurology - movement disorders. London, UK: Wolters Kluwer Health Medical Research; 2012.
  • Morris JG, Jankovic J. Neurological clinical examination. London: Hodder & Stoughton Limited; 2012.
  • Fahn S, Jankovic J, Hallett M. Principles and practice of movement disorders. Philadelphia: Churchill Livingstone, Elsevier; 2011. Includes on-line videos and references. [View book]
  • Hallett M, Cloninger CR, Fahn S, Halligan P, Jankovic J, Lang AE, et al. Psychogenic movement disorders and other conversion disorders. Cambridge, UK: Cambridge University Press; 2011.
  • Singer HS, Mink JW, Gilbert DL, Jankovic J. Movement disorders in childhood. Philadelphia: Butterworth-Heinemann (Elsevier); 2010.
  • Albanese A, Bigalke H, Foster K, Hallett M, Jankovic J, Montecucco C, et al. Toxins 2008: basic and therapeutic aspects of botulinum and tetanus toxins. Toxicon. Philadelphia: Elsevier Ltd.; 2009.
  • Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer N, editors. Botulinum toxin. Therapeutic clinical practice and science. Philadelphia: Saunders (Elsevier); 2009.
  • Jankovic J, editor. Movement disorders. Neurologic clinics. Philadelphia: W.B. Saunders, Elsevier; 2009.

Book Chapters and Other Publications (Selected out of 87)

  • Adam O, Jankovic J. Treatment of dystonia. In: Watts RL, Standaert DG, Obeso JA, editors. Movement disorders: Neurologic principles and practice. 3rd ed. New York: McGraw-Hill; 2012. p. 587-601.
  • Azher SN, Jankovic J. Idiopathic basal ganglia calcification. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2007-. Available from: [View online multimedia]
  • Diamond A, Jankovic J. Genetics of movement disorders. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2005-. Available from: [View online multimedia]
  • Diamond A, Jankovic J. Quality of life and cost effectiveness of deep brain stimulation in movement disorders. In: Vitek J, Starr P, Okun M, Tarsy D, editors. Deep brain stimulation for neurological and psychiatric disorders. Totowa (NJ): Humana Press; 2012. (in press).
  • Fekete R, Jankovic J. Multiple system atrophy. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2010-. Available from: [View online multimedia]
  • Ferrara JM, Jankovic J. Acquired (non-Wilsonian) hepatocerebral degeneration. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2007-. Available from: [View online multimedia]
  • Ferrara JM, Jankovic J. Dopa responsive dystonia. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2007-. Available from: [View online multimedia]
  • Frank SA, Jankovic J. Corticobasal degeneration. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2010-. Available from: [View online multimedia]
  • Ha A, Jankovic J. Huntington disease. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2010-. Available from: [View online multimedia]
  • Ha A, Jankovic J. Paroxysmal dyskinesias. In: Gilman S, editor. Neurology-Medlink. Arbor Publishing, La Jolla, CA; 2012. Annual updates 2012-. Available from: [View online multimedia]

Poster and Platform Presentations (Selected out of 294)

  • Jimenez-Shahed J, York M, Smith-Gloyd EM, Jankovic J, Viswanathan A. MER vs. MRI guidance in placement of DBS electrodes for Parkinson's disease. Presented at the Movement Disorder Society (MDS), 18th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden (June 8-12, 2014). [View poster]
  • Charles P, Jankovic J, Comella C, Stacy M, Schwartz M, Manack A, et al. Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Treatment patterns and subject disposition. Neurology. 2014;82(Meeting Abstracts 1):P7.062. [View poster]
  • Comella C, Perlmutter J, Jinnah H, Adler C, Barbano R, Factor S, et al. Clinimetric testing of the modules for the Comprehensive Cervical Dystonia Rating Scale (CCDRS). Neurology. 2014;82(Meeting Abstracts 1):S27.004. [Platform Presentation]
  • Jankovic J, Adler C, Charles P, Comella C, Stacy M, Schwartz M, et al. Treatment outcomes in Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE). Neurology. 2014;82(Meeting Abstracts 1):P7.069. [View poster]
  • Patel N, Hanfelt J, Marsh L, Jankovic J. Alleviating maneuvers (sensory tricks) in cervical dystonia. Neurology. 2014;82(Meeting Abstracts 1):P2.046. [View poster]
  • Waln O, Wu Y, Perlman R, Van AK, Wendt J, Jankovic J. Dopamine transporter imaging in essential tremor with and without parkinsonian features. Neurology. 2014;82(Meeting Abstracts 1):S57.002. [Platform Presentation]
  • Wijemanne S, Jankovic J. Hereditary spastic paraplegia due to a novel mutation in SPG11 gene presenting as dopa responsive dystonia, parkinsonism and spasticity. Neurology. 2014;82(Meeting Abstracts 1):P4.057. [View poster]
  • Patel N, Hanfelt J, Marsh L, Jankovic J, for the Dystonia Coalition. Alleviating maneuvers (sensory tricks) in cervical dystonia. Presented at the Movement Disorder Society (MDS), 17th International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia (June 16-20, 2013). [View poster]
  • Dhungana S, Jankovic J. Movement disorders in golfers. Neurology. 2013;80(Meeting Abstracts 1):P02.070. [View poster]
  • Fernandez H, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, et al. XCiDaBLE: An observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Interim results from the first 145 subjects with cervical dystonia. Neurology. 2013;80(Meeting Abstracts 1):P07.192.

E-mail this page to a friend